Clinical trial NCT01564147: More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR)
Official title: More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Rheumatoid Arthritis
Keywords: Therapeutic Education, Rheumatoid Arthritis
Lead sponsor: Nantes University Hospital
Sponsor class: OTHER
First posted: 2012-03-27
Enrollment: 62
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL

Brief summary: Taking into account the recommendations of the Health Authority \[1\] and the application of patients' associations, we have structured a course of therapeutic education includes three stages for patients with rheumatoid arthritis and followed at Nantes University Hospital. Step 1: initial interview with a nurse patient education for diagnosis and education with the patient to choose three subjects from among 10 offered him problematic; Step 2: Orientation in an educational path that provides access to 6 months group workshops (3 maximum) and / or interviews tailored to the three selected topics; Step 3: final interview with a nurse said therapeutic education formative assessment to take stock. The main objective of our work is to ensure that the patient finds it easier solutions to the three problematic topics him after 6 months of education after six months without treatment.


Eligibility criteria: Inclusion Criteria:

* Patient presenting at clinics for Rheumatology or the Rheumatology Day Hospital at the University Hospital or hospitalized in the department of Rheumatology
* Men or women
* Having signed the consent
* major
* Affiliated to social security or covered by the CMU
* Patient with rheumatoid arthritis meeting the ACR criteria
* Patient with rheumatoid arthritis stable for at least 6 months (change in DAS 28 \<1.2)

Exclusion Criteria:

* Patient can not understand the information
* Patient confined to bed or chair, unable to care for himself or not doing with difficulty
* pregnant patient
* minors
* Adults under guardianship

Primary outcomes:
measure: EVA measures the overall ability to find solutions applicable to their situation
timeFrame: 12 months
Secondary outcomes:
measure: EVA measures the ability to find solutions applicable to their situation for each of the three problems identified.
timeFrame: 12 months
measure: Knowledge (score / 10) treatments for rheumatoid arthritis, knowledge (note/10) signs of a flare of rheumatoid arthritis.
timeFrame: 12 months
measure: Self-efficacy against a disease flare (EVA), self-efficacy against a side effect of treatment (EVA)
timeFrame: 12 months
measure: RAPID score 4 (scale)
timeFrame: 12 months
measure: EVA measuring fatigue
timeFrame: 12 months
measure: Duration of morning stiffness in minutes or hours.
timeFrame: 12 months
measure: CRP and VS
timeFrame: 12 months
measure: Scale of STAI S Scale of STAI S
timeFrame: 12 months
measure: Beck Scale
timeFrame: 12 months
measure: Evaluation Test of adherence of Girerd
timeFrame: 12 months
measure: Dosage Cortancyl or Solupred.
timeFrame: 12 months
measure: Number of visits to physician, rheumatologist at at therapist, psychiatrist, occupational physician, number of hospitalizations, number of meetings with occupational therapist, social worker, dietician, physiotherapist, psychologist...
timeFrame: 12 months
measure: Patient satisfaction with respect to information received, the caller and the improvement in different areas of health (EVA)
timeFrame: 12 months
measure: Attendance at meetings / workshops offered after the initial diagnosis.
timeFrame: 12 months
Other outcomes:
Locations:
city: Nantes
country: France
facility: Maugars
Study officials:
affiliation: Nantes University Hospital
name: Yves Maugars, PU-PH
role: PRINCIPAL_INVESTIGATOR
References: